Advances in autologous stem cell and biomaterial engineering are transforming the future of regenerative medicine by enabling scalable, patient-derived therapies.
- CGT Manufacturing Shifts From Capacity To Strategy
- Rethinking CQV In A Digital, Agile Manufacturing Landscape
- Will FDA's One-Day Inspection Pilot Stand The Test Of Time?
- The Next Frontier In Women's Cancer Care: Combining Cell Therapy With Immuno-Oncology
- Spine Care Redefined: Autologous Cell Therapy For Degenerative Disc Disease
- A Multi-Agent Audit Intelligence Framework For CDMO Quality Oversight
- Why Contamination Control By Design Should Matter To Your CDMO
- Repeating Sanofi's Ballroom Design On Two Continents
CELL & GENE ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
![Organs-body-organoid-study-GettyImages-1157550305]( "A Study To Assess Organoid Size And Cell Count From 3D Image Analysis")
A Study To Assess Organoid Size And Cell Count From 3D Image AnalysisRecent advancements in 3D patient-derived organoids (PDOs) offer improved predictive power over traditional 2D assays. Explore a patented bioprocess for PDO expansion that could revolutionize drug discovery, especially in oncology.
-
![Viral Safety In Monoclonal Antibody Manufacturing-Getty-184714532]( "Study Viral Infection In Resting Humans CD4+ T Cells With Synthetic sgRNAs")
Study Viral Infection In Resting Humans CD4+ T Cells With Synthetic sgRNAsDiscover how Synthego's proprietary synthetic sgRNA, combined with Lonza’s 4D-Nucleofector®, enabled highly efficient gene editing in resting human CD4+ T cells.
-
![GettyImages-2036497686-lab-team-collaboration-laboratory-tablet-computer]( "Fast And Accurate Detection Of Alzheimer's Disease Targets")
Fast And Accurate Detection Of Alzheimer's Disease TargetsIn this study, the detection of three Alzheimer’s disease targets are highlighted: Human BDNF (Brain-derived neurotrophic factor), Tau, and TREM2 (Triggering receptor expressed on myeloid cells 2).
-
![Organs-body-organoid-study-GettyImages-1157550305]( "Bench To Bedside: Trends In Regenerative Medicine")
Bench To Bedside: Trends In Regenerative MedicineDiscover the promising capabilities of regenerative medicine. Learn about four advanced techniques that can restore damaged tissue and offer hope to patients with severe conditions.
-
![GettyImages-1309776504-viral-inspection-laboratory-scientists]( "Streamlining AAV And LVV Manufacturing Platform Solutions")
Streamlining AAV And LVV Manufacturing Platform SolutionsObserve how streamlined, scalable platforms are transforming viral vector manufacturing to accelerate the delivery of cell and gene therapies to patients.
-
![GettyImages-2152031133-atom-hand-gear-wrench-automation]( "Parallel Line Analysis And Relative Potency")
Parallel Line Analysis And Relative PotencyExplore parallelism testing methods, including response and parameter comparison tests, with innovative software to ensure accurate results with detailed protocols for linear and non-linear regression curves.
-
![GettyImages-1626470215-cluster-cells-stem-cells-blue]( "Functional Characterization Of 3D Assembled Neurospheres")
Functional Characterization Of 3D Assembled NeurospheresNeural organoids and 3D spheroids offer advanced platforms for brain research and drug discovery. Discover how creating 3D neurospheres from iPSC-derived neurons and astrocytes aids in compound profiling and toxicity testing.
-
![GettyImages-1388387927-computer-scans-brain-doctor-pen]( "Assessing Viability And Real-Time Apoptosis/Necrosis")
Assessing Viability And Real-Time Apoptosis/NecrosisMalignant gliomas are aggressive brain tumors that resist standard treatments. Discover why researchers focus on real-time cell death dynamics to develop targeted therapies and promising strategies.
-
![GettyImages-1142684567 cell culture]( "Consistent Improvement In CHO-K1 GS Performance With Efficient-Pro Feed 3 And Efficient-Pro Feed Enhancer")
Consistent Improvement In CHO-K1 GS Performance With Efficient-Pro Feed 3 And Efficient-Pro Feed EnhancerOptimize your CHO-K1 GS cell line with advanced chemically defined, animal origin-free feeds. Achieve higher titers and reliable product quality.
-
![GettyImages-1289625867 chromatography]( "Simplify Your Bioprocess Development With Custom Buffers")
Simplify Your Bioprocess Development With Custom BuffersTailor your bioprocess for optimal cell growth, gene expression, and therapeutic production with custom buffers to ensure precise control over pH, ion concentrations, and nutrient availability.
NEWSLETTER ARCHIVE
- 05.28.26 -- Accelerate Your Assay And Imaging Data With These New Tools
- 05.28.26 -- Dr. Peter Marks On Why Gene Therapy May Need A New Regulatory Playbook
- 05.27.26 -- Smarter Processing For Workflows From Discovery To Commercial Scale
- 05.27.26 -- Rethinking Sterile Welding In Bioprocessing
- 05.27.26 -- Bridging Analytical Gaps To Ensure CGT Material Quality
- CGT Manufacturing Shifts From Capacity To Strategy
- Dr. Peter Marks On Why Gene Therapy May Need A New Regulatory Playbook
- Regeneron Advances In Vivo Gene Therapy For Hearing Loss
- Sana, Mayo Clinic Advance A New Model For Cell Therapy Delivery In T1D
- Reprogramming T-Cell Access To Solid Tumors Through Improved Trafficking And Entry
CELL AND GENE CONTENT COLLECTIONS
While there are opportunities to scale, there are also manufacturing gaps, capacity issues, and production timelines that require improvement to do so. And then, of course, there’s cost. Because scale up and scale out are significant to everyone in the sector, we’ve curated insightful editorial that addresses the most important aspects of scalability.
More Content Collections
